JSPR
Jasper Therapeutics, Inc. Common Stock
stockNASDAQ
At CloseNov 6, 2026 3:59:35 PM EST
16.90USD+20.063%(+2.82)63,386
JSPR Financials
In Q2 FY 2026 (ended ), Jasper Therapeutics, Inc. Common Stock (JSPR) reported net income of −$2.76M, operating cash flow of −$6.92M, and assets of $11.8M (filed ).
Loading financial statements…